… the gastroenterologist a comprehensive summary of the … Cisapride was introduced worldwide
in the 1990s as a serotonin 5-… this withdrawal of tegaserod was a report by the Swiss drug …

… Results: Tegaserod was withdrawn in 2007 due to increased … and mucosal application of
serotonin activates local reflex … a concise summary of the abovementioned drugs used for …

… We did not measure lower gastrointestinal motility directly in … by treatment group using summary
statistics for baseline, each … Tegaserod was withdrawn because of its association with an …

… Tegaserod appeared as safe as other drugs for IBS-C in … adverse event, resulting in study
drug discontinuation in 6.5% and 0.7… opioid receptors, gut serotonin receptors, secretagogue …

… [Citation52], was withdrawn from the market after the report of … of tegaserod [Citation54]
led to a new approval of the drug … agents to treat gastrointestinal motility disorders [Citation66]. …

… for the treatment of functional motility disorders of the … on platelet aggregation induced by
ADP and serotonin plus … Following the voluntary withdrawal of tegaserod due to potential CV …

… improvement, such as Tegaserod (5-hydroxytryptamine4 (5-… selective serotonin reuptake
inhibitors (SSRIs) and serotonin–… strong laxative and improves the gastrointestinal motility [86]. …

… or secondary care, but careful explanation as to the rationale for their … motility may be
influenced by alterations in serotonin (5-… Removal of the reacting antigen from the diet improved …

… lack a clear pathophysiology explanation and an effective management … Neurotransmitters
such as serotonin via 5-… Tegaserod was withdrawn from the market in 2007 due to possible …

… Tolerability was defined as discontinuation of treatment due … sufficient cost data to include
tegaserod or tenapanor in this … Scholar Award in Functional GI and Motility Disorders, which …